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Abstract
Background: The main morphological features of primitive cells, such as stem and progenitor cells, are that these
cells consists only one nucleus. The main purpose of this study was to determine the differentiation capacities of
stem and progenitor cells. This study was performed using mononucleated cells originated from murine peripheral
blood and MC3T3-E1 cells. Three approaches were used to determine their differentiation capacities: 1) Biochemical
assays, 2) Gene expression analysis, and 3) Morphological observations.
Results: We found that both cells were able to differentiate into mature osteoblasts, as assayed by ALP activity.
RT-PCR analysis showed the activation of the Opn gene after osteoblast differentiation. Morphological observations
of both cells revealed the formation of black or dark-brown nodules after von Kossa staining. Nevertheless, only
mononucleated cells showed the significant increase in TRAP activity characteristic of mature osteoclasts. The
osteoclast-specific CatK gene was only upregulated in mononucleated cells. Morphological observations indicated
the existence of multinucleated osteoclasts. Sca-1 was activated only in undifferentiated mononucleated cells,
indicating that the cells were hematopoietic stem cells. In both cell lines, the housekeeping Gapdh gene was
activated before and after differentiation.
Conclusion: The isolated mononucleated cells were able to differentiate into both osteoblasts and osteoclasts;
indicating that they are stem cells. On the other hand, MC3T3-E1 cells can only differentiate into osteoblasts; a
characteristic of progenitor cells.
Background
The advent of stem cell technology provides remarkable
opportunities for the improvement and extension of
human life. Stem cell research has spread into many fields
of study, indicating that it represents an area with great
scientific and therapeutic promise. Their unique ability to
self-renew indefinitely and to differentiate into multiple
cell types can make them useful to elucidate normal cellu-
lar processes as well as to understand their mechanisms
[1]. In contrast, progenitor cells are unipotent proliferative
cells with a limited capacity for self-renewal. The unipo-
tency of progenitor cells is depending on the type of their
parent stem cell as well as their physiological niche.
Progenitors are said to be in a more advanced stage of cell
differentiation [2] that is between multipotent stem cells
and fully differentiated cells.
Opinion among researchers regarding the definitions
of stem and progenitor cells is still evolving. For exam-
p l eS e a b e r ga n dv a nd e rK o o y[ 3 ]h a ds t a t e dt h a ts o m e
researchers exclude the characteristic of stem cells plas-
ticity as one of the novel property of stem cells. They
also suggested that there are differences in the biological
marker of these two cell types, i.e., hematopoietic stem
cells and progenitor cells detected in both in vivo and
in vitro studies. Therefore, a few potential biological
markers, such as Thy-1 and Sca-1 have been used to
prove the difference for respective cells.
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a chosen hematopoietic stem cell marker. Sca-1 is a
membrane-anchored protei nf r o mt h em u r i n eL y - 6
family mouse strain. Sca-1 regulates hematopoietic stem
cell self-renewal and the development of specific pro-
genitor populations, such as blood cells [4]. Its expres-
sion has been extensively used as a marker of
hematopoietic stem cells, [4,5] thus there is no expres-
sion of Sca-1 in progenitor cells.
Cellular differentiation has been extensively studied for
many years and has become one of the most important
areas of research, especially in the medical field. Informa-
tion about the cells development gained from biochem-
ical assays, characterizations of cell morphology, and
gene expression is being used to elucidate the fundamen-
tal mechanisms of cell differentiation. The differentiation
of stem and progenitor cells into specialized cell types in
charge of bone remodelling is important for the mainte-
nance of mineral homeostasis and the repair of micro-
fractures. Skeleton growth and bone remodelling are
continual processes involving two specialized cells known
as osteoblasts, which deposit the organic and inorganic
components of the bone matrix, and osteoclasts, which
remove bone matrix [6,7]. The research of Duplomb et al
[8] on osteoblast and osteoclast differentiation using
embryonic stem cells has contributed to the understand-
ing and harnessing of bone homeostasis.
The maintenance of bone homeostasis is essential for
the functional skeleton, including skeletal growth, repair
of skeletal damage and replacement of aged bone. Bone
remodelling is a continual process, which involves osteo-
blast and osteoclast cells, which are originate from differ-
ent cell lineage [9]. Osteoblasts are believed to originate
from common mesenchymal progenitors, known as mul-
tipotent mesenchymal stem cells [10]. These multipotent
mesenchymal stem cells have been studied extensively
for their capability to give rise to a number of cell
lineages, such as adipocytes, myoblasts and chondrocytes.
Importantly, the differentiated osteoblast is responsible
for the formation of new bone matrix. In their in vivo
microenvironment, osteoblasts also produce factors that
regulate the formation of osteoclasts and osteoclastic
activity [7]. Osteoclasts are multinucleated cells derived
from hematopoietic stem cells and are responsible for
bone resorption. Bone resorption is important in many
skeletal processes, e.g., bone growth, tooth eruption and
fracture healing [11]. Both osteoblasts and osteoclasts
originate from different lineage, therefore it can be used
to prove the capacity of stem cell to differentiate into
other cell lineage rather than progenitor cells.
During the process of differentiation and/or matura-
tion, the expression patterns of many genes are modu-
lated in pluripotent cells. The specific expression pattern
of a collection of known genes during this process has
established them as differentiation markers [12]. Osteo-
blasts express several genes as markers of their differen-
tiation, including osteopontin, alkaline phosphatase and
osteocalcin [7,13-16]. However, osteopontin is one of the
potential markers, which was widely used among
researchers in osteoblasts study along with alkaline phos-
phatase [16-18].
Osteopontin (Opn), also known as early T cell activa-
tion gene-1, or eta-1, is a secreted, acidic glycoprotein
with pleiotropic effects. The interaction of Opn with
integrins and CD44 activates several different signaling
pathways during the differentiation process [17]. Beck et
al [16] used gene array technology to explain changes in
gene expression during the differentiation of the mouse
calvarial-derived MC3T3-E1 cell line and osteopontin
was one of the genes identified as a biological marker.
Kumar et al [18] used osteopontin promoters to trans-
duce mouse mesenchymal stem cells before evaluating
the expression of this bone-specific promoter.
Osteoclasts were shown to synthesize and secrete
cathepsin K (CatK) into the extracellular compartment
at the attachment site between osteoclasts and the bone
surface [19]. Recent investigations have shown that
CatK, a lysosomal enzyme is synthesized specifically by
cells in the osteoclast lineage [20,21]. Therefore, CatK is
an essential marker of bone resorption.
Morphological characterizations of osteoblasts and
osteoclasts are evaluated by von Kossa and May Grun-
wald-Giemsa staining, respectively. For osteoblasts, alka-
line phosphatase expression is considered an early
differentiation marker, while von Kossa staining identifies
the late differentiation stage of osteoblasts due to its cap-
ability to label calcium minerals [11]. The mineralized
nodule formation in mature osteoblasts can be revealed by
von Kossa silver staining and visualized as metallic silver.
Similar study by Tsuang et al [11] using this staining have
verified the mineralization nodules formation of osteoblas-
tic cell that been affected by caffeine. On the other hand,
May Grunwald-Giemsa staining is used to observe the
nuclear morphology of osteoclasts. The nucleus is stained
by May Grunwald, while Giemsa stains the cytoplasm,
thus highlighting the typical characteristics of mature mul-
tinucleated osteoclast cells. May Grunwald-Giemsa stain-
ing were widely used in cellular and microbiological
research. Recent studies using May Grunwald-Giemsa
staining on Flt3+ bone marrow progenitor cells able to
show the existence of osteoclastic differentiated cells in
the presence of M-CSF and RANKL [22,23]. In this study,
we applied von Kossa and May Grunwald-Giemsa staining
on both primary mononucleated and MC3T3-E1 cells to
observe the ability of these to differentiate into osteoblast
and osteoclast cells respectively.
Therefore, we aimed to characterize the differences
between stem and progenitor cells in vitro by analyzing
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approaches: biochemical assays, morphological charac-
terization and genetic analysis involving Opn, CatK and
Sca-1 expressions. The TRAP and ALP assays permit
the simultaneous analysis of both of the bone metabo-
lism enzymes tartrate-resistant acid phosphatase (TRAP)
and alkaline phosphatase (ALP). Morphological observa-
tions were based on the formation of calcium nodules,
as determined by von Kossa staining, and large multinu-
cleated cells, as determined by May Grunwald-Giemsa
staining, in osteoblasts and osteoclasts, respectively.
Finally, the activation of the Opn gene in osteoblasts
and CatK in osteoclasts supported the identification of
each cell type.
Results
Biochemical Assays
Two different biochemical assays were carried out to mea-
sure osteoblast and osteoclast differentiations: alkaline
phosphatase (ALP) and tartrate resistant acid phosphatase
(TRAP) assays. ALP is a biochemical marker of osteo-
blasts, while TRAP is a biochemical marker of osteoclasts,
as the ALP and TRAP enzymes are secreted during osteo-
blast and osteoclast differentiation, respectively.
Figure 1A shows the percentage of ALP activity during
osteoblast differentiation. ALP activity in mononucleated
and MC3T3-E1 cells gradually increased from day 3 to
day 14 of osteoblast differentiation. This increment
was statistically significant (p < 0.05) at days 7, 10 and 14
for MC3T3-E1 cells, and this was true at days 10 and 14
for mononucleated cells. Therefore, both cell types suc-
cessfully differentiated to osteoblasts. As depicted in
Figure 1B, TRAP activity in mononucleated cells during
osteoblast differentiation fluctuated from the beginning
of differentiation. The activity was significantly increased
at day 5, decreased at day 7 and significantly increased
at days 10 and 14. TRAP activity in MC3T3-E1 cells
remained constant similar to control. The control is where
the cells were not exposed to the differentiation factors.
In osteoclast differentiation, the ALP activity of mono-
nucleated cells was unstable and not significantly differ-
ent (p > 0.05) from the control. In addition, the ALP
activity in MC3T3-E1 cells also remained similar to the
control activity. During the TRAP assay, only mononu-
cleated cells showed an increase of TRAP activity starting
from day 3 of osteoclast differentiation induction. As
s h o w ni nF i g u r e2 ,t h e r ew a sas i g n i f i c a n ti n c r e a s eo f
TRAP activity at days 7 and 10 of osteoclast differentia-
tion, indicating that the mononucleated cells differen-
tiated into osteoclasts. In contrast, MC3T3-E1 cells
showed similar TRAP activities to the controls (Figure 2).
Therefore, enzymological assays demonstrated that suc-
cessful osteoblast and osteoclast differentiation only
occurred in mononucleated cells.
Activation of Opn, CatK, Sca-1 and Gapdh Genes
We compared the gene expression profiles of mononu-
cleated and MC3T3-E1 cells in the undifferentiated and
differentiated states to further confirm their differentia-
tion capacities. Previous studies have shown that there
are several specific gene markers for osteoblasts, for
example, osteopontin (Opn), alkaline phosphatase (Alp)
and osteocalcin (Ocn) [7,13,15,16]. The gene markers we
used for osteoclasts were tartrate-resistant acid phospha-
tase (Trap) and cathepsin K (CatK) [9].
The RT-PCR analysis showed the activation of Opn
expression in mononucleated and MC3T3-E1 cells after
being cultured for 14 days in osteoblast differentiation
media. The amplification of the Opn transcript, with a
size of 234 bp, is shown in Figure 3i. For the osteoclast
differentiated cells, the expression of CatK was detected
only in mononucleated cells after 10 days of culturing in
osteoclast differentiation media. As shown in Figure 3ii,
only the mononucleated cells contained the 350-bp
CatK transcript.
The Sca-1 gene was activated only in undifferentiated
mononucleated cells, as shown by the amplification of
the 167-bp Sca-1 transcript (Figure 3(iii)). The Gapdh
gene was activated in both cell lines, before and after
differentiation, as shown by the RT-PCR product of 717
bp (Figure 3iv). All the amplified cDNA, i.e. Opn, CatK,
Sca-1 and Gapdh, were subjected to DNA sequencing
and verified using blastn program from NCBI.
Morphological Analysis of Differentiated Cells
Figure 4A and 4B show the differentiated osteoblasts from
mononucleated and MC3T3-E1 cells, respectively. Both
cells were able to differentiate into osteoblasts. We visua-
lized the extent of their differentiation into osteoblasts
with von Kossa staining, which produces stained calcium
nodules. The black arrows show the formation of nodules
in differentiated mononucleated cells (Figure 4A) and
MC3T3-E1 cells (Figure 4B).
We quantified the percentage of differentiated osteo-
blasts from mononucleated cells and found that they
could be classified into three distinct classes, according to
the color of the von Kossa-stained nodules: undifferen-
tiated, semi-differentiated and fully-differentiated cells.
The undifferentiated cells (controls) did not show any
stained nodules. A light-brown color represented the
semi-differentiated cells, while dark-brown or black cells
were fully differentiated cells. Figure 5 shows that at day
7, ~32% of the mononucleated cells were semi-differen-
tiated into osteoblasts, while ~29% of the mononucleated
cells were fully differentiated osteoblasts. At day 10 of dif-
ferentiation, the percentages were increased to 42% and
40%, respectively. At the end of osteoblast differentiation
(day 14), the percentage of semi-differentiated osteoblasts
increased to 50%, while fully differentiated osteoblasts
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semi-differentiated and fully-differentiated osteoblasts
were increased upon differentiation. Although semi-dif-
ferentiated and fully differentiated osteoblasts were
increased gradually, the percentage of fully differentiated
osteoblast cells was less than semi-differentiated osteo-
blasts (Figure 5). After 14 days differentiation, we found
that the cells were still not 100% differentiated. Other
studies have demonstrated that osteoblast were 100% -
differentiated until 21 days cultured in osteoblast
Figure 1 ALP and TRAP activities in osteoblast differentiation. (A) ALP activities during osteoblast differentiation. There was significantly
increased ALP activity in mononucleated cells at days 10 and 14 of differentiation, while MC3T3-E1 cells showed significant increases at days 7,
10 and 14 of differentiation. (B) TRAP activities during osteoblast differentiation. There were significant increases of TRAP activity in
mononucleated cells at days 5, 10 and 14 of osteoblast differentiation. The TRAP activity in MC3T3-E1 remains constant and similar to control
activity. Results are presented as mean ± SD (n = 3). The * and § indicate significant difference (p < 0.05) of mononucleated cells and MC3T3-E1
respectively as compared with day 0.
Yazid et al. Cancer Cell International 2010, 10:42
http://www.cancerci.com/content/10/1/42
Page 4 of 12Figure 2 TRAP assay in osteoclast differentiation. Assays were performed after 3, 5, 7 and 10 days of differentiation. The graph shows that
only mononucleated cells exhibited a significant increase of TRAP activity after 7 and 10 days of osteoclast differentiation. TRAP activity in
MC3T3-E1 remained constant, similar to control activity. Results are presented as mean ± SD (n = 3). The * indicate significant difference (p <
0.05) of mononucleated cells and MC3T3-E1 respectively as compared with day 0 activity for the same culture period.
Figure 3 Expression of specific gene markers. The RT-PCR analysis was performed using RNA isolated from mononucleated and MC3T3-E1
cells before and after differentiation into osteoblast and osteoclast cells. (i) The expression of Opn (234 bp) indicates differentiation into mature
osteoblasts. (ii) CatK (350 bp) expression shows osteoclast differentiation. (iii) The activation of Sca-1 (167 bp) is indicative of the degree of
stemness of the cells. (iv) Gapdh (717 bp) was used as a positive control. (v) The labelled 100 bp DNA marker to identify the approximate size of
amplicons. Equal volumes of the products were separated in agarose gels using 100 bp DNA markers and stained with ethidium bromide.
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only to indicate that both the primary mononucleated
and MC3T3-E1 cells have capability to differentiate into
osteoblast.
Mature osteoclasts have more than one nucleus and
are very large in size [11,25]. The nucleus is stained as
dark purple with May-Grunwald Giemsa, while the
cytoplasm is stained lighter (pink rose) than the nucleus.
No multinucleated cells formed in the undifferentiated
cells (control). Mononucleated cells cultured in osteo-
clast differentiation media for 10 days exhibited the
aforementioned criteria of osteoclast cells, as shown by
the black arrows (Figure 6A). In contrast, MC3T3-E1
cell morphology did not show any multinucleated cells
Figure 4 Morphology of differentiated osteoblast cells. (A) Morphology of differentiated murine mononucleated cells. (B) Morphology of
differentiated MC3T3-E1 cells. Both cells were cultured in osteoblast differentiation media for 5, 7, 10 or 14 days prior to morphological analysis
by von Kossa staining. The black arrows show the formation of light-brown, dark-brown or black nodules (400× magnification).
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tiation media. Therefore, the MC3T3-E1 cells did not
differentiate into osteoclasts (Figure 6B). These data
indicate that only mononucleated cells had the capacity
to differentiate into osteoclasts.
From these data, we were able to quantify the percen-
tage of osteoclast-differentiated cells according to two
different classes, undifferentiated and differentiated cells.
Photographs of the cells were selected at random and
counted prior to the percentage analysis. The percentage
of fully differentiated osteoclasts increased with time
(Figure 7). Approximately 6% fully differentiated osteo-
clasts were observed at day 5 of osteoclast differentia-
tion. The percentage of fully differentiated osteoclast
cells increased to 12% and 32% at days 7 and 10 of
osteoclast differentiation, respectively (Figure 7).
Discussion
The differentiation of stem cells is widely studied
because of their biological properties and potential med-
ical importance. Unfortunately, the ambiguity of the dis-
tinctions between stem and progenitor cells continues
to puzzle stem cell researchers. Therefore, we studied
the differentiation of stem cells primarily isolated from
murine peripheral blood and progenitor cells originating
from mouse calvaria to compare their differentiation
capacities. The approaches that we took showed that the
mononucleated cells were able to differentiate into both
osteoblasts and osteoclasts, whilst the MC3T3-E1 cells
could only differentiate into osteoblasts. Therefore, this
study demonstrates that the primary mononucleated
cells are stem cells, but the osteoblast progenitor
MC3T3-E1 cell line is not.
ALP enzyme activities at day 14 were highest when
mononucleated and MC3T3-E1 cells were cultured in
osteoblast differentiation media. These data proved that
both cells were differentiated into osteoblast cells. The
increment of ALP activity during osteoblasts differentia-
tion was also proved by Wang et al [24] and Zhao et al
[25]. Their studies shows that MC3T3-E1 pre-osteoblast
was differentiated into osteoblast cells after induced
with ascorbic acid and b-glycerophosphate for 14 days.
The complement of the osteoblast is the osteoclast,
which is multinucleated and large in size. A large
amount of TRAP enzyme is secreted during osteoclast
differentiation. TRAP was secreted at the highest levels
at day 10 of osteoclast differentiation (Figure 2). We
performed a TRAP assay to detect the degree of osteo-
clast differentiation in both cell lines and found that
TRAP activity was significantly increased only in mono-
nucleated primary cells. These data are in accord with
the findings of Intan Zarina et al [13,14], who reported
that TRAP activity is increased at day 10 of osteoclast
differentiation. The mononucleated cells, therefore, had
the capacity to differentiate into both osteoclasts and
osteoblasts.
Nevertheless, there were fluctuations of TRAP activity
in the mononucleated cells during osteoblast differentia-
tion. This result was similar to that of Perez-Amodio et
al [26], who found fluctuating TRAP activity during the
first 7 days of osteoblast differentiation. They proposed
that the fluctuation of TRAP activity may have been
caused by the activation and deactivation of TRAP by
cysteine proteinases [27]. Therefore, the fluctuation of
TRAP in our study may have had a similar cause.
In contrast, the MC3T3-E1 cells were intrinsically
programmed to differentiate into their committed target
cells, as they were unable to differentiate into osteo-
clasts. MC3T3-E1 is known to be an osteoblast progeni-
tor committed to a specific lineage, which originated
from mesenchymal stem cells [28]. When the MC3T3-
E1 cells were cultured in osteoclast differentiation med-
ium, the ALP and TRAP activities remained constant,
similar to the control cells. These results indicate that
Figure 5 Percentage of cells differentiated into osteoblast. The percentages of differentiated cells were calculated upon 14 days of
osteoblast differentiation and classified into two categories, semi-differentiated and fully differentiated osteoblasts.
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cells other than osteoblasts.
The activation of genetic markers for each differen-
tiated cell type is a reliable indicator for the successful
differentiation of cells in vitro. The activation of Opn
demonstrates that the cells have differentiated into osteo-
blasts, while the activation of CatK indicates osteoclast
differentiation. In this study, we showed that Opn and
CatK genes were activated in the primary mononucleated
cells that had been differentiated into osteoblasts and
osteoclasts, respectively.
Based on rat calvarial osteoblast-like (ROB) cell studies,
Opn is expressed during day 13 to day 15 of osteoblast
differentiation. ROB cells can be fully differentiated into
matured osteoblasts [28]. Other studies have reported
that Opn expression is modulated by osteoblast stimula-
tion in vivo, resulting in dramatically increased Opn
[17,29]. We showed that both primary mononucleated
Figure 6 Morphology of differentiated osteoclast cells. May Grunwald-Giemsa staining of (A) multinucleated osteoclasts and (B) MC3T3-E1
cells. Both cells were subjected to cytospin at day 3, 5, 7 or 10 differentiations prior to May Grunwald-Giemsa staining. The figure shows that
the numbers of multinucleated osteoclast cells increased upon differentiation of mononucleated cells but not MC3T3-E1 cells. The black arrows
show the multinucleated osteoclasts (400× magnification).
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into matured osteoblast cells.
Differentiation of mononucleated cells into mature
osteoclasts was indicated by the activation of the CatK
gene. The CatK gene has been widely used as an osteo-
clast marker in many previous studies. Hu et al [30]
reported that the expression of CatK is increased during
osteoclast differentiation in myeloid progenitor cells.
Another recent study showed increased CatK expression
during osteoclastogenesis [31]. The function of CatK in
osteoclasts could account for their osteoclastic activities.
According to Väänänen et al [32], a high level of CatK
expression secreted by osteoclasts in the lacuna is an
indicator of the resorption process. Another study
showed that CatK is expressed during the resorption of
calcium deposits in calcified tendonitis of the rotator cuff
tendons, suggesting CatK as a potential osteoclast marker
[20]. Our study shows that the activation of CatK was
found only in mononucleated cells after 10 days cultured
in osteoclast differentiation media. This is an indication
that only mononucleated cells were able to differentiate
into osteoclast, but not the MC3T3-E1 cell line.
Cells express many genes responsible for cell survival,
such as Gapdh (glyceraldehyde-3-phosphate dehydro-
genase) and b-actin, which are involved in glycolysis
and cell development, respectively [33]. These house-
keeping genes are frequently used to normalize mRNA
levels between different samples. However, the expres-
sion of these genes may vary among tissues or cells and
may change under certain circumstances [34]. In this
study, Gapdh was used as a positive control for primary
mononucleated and MC3T3-E1 cells. Its expression was
constant in both types of cells, before and after differen-
tiation. The RT-PCR amplification product of Gapdh
(717 bp) remained activated in all respective cells and
conditions (Figure 3), indicating that the cells undergo
survival processes [35].
As both types of cells are derived from mice, the cells
were examined for Sca-1 (stem cell antigen-1) activation.
We found that only undifferentiated mononucleated
cells activate the Sca-1 gene (Figure 3). Sca-1 is encoded
by the strain-specific Ly-6 E/A gene, and its expression
revealed that mononucleated cells are hematopoietic
stem cells [4].
The morphological analysis in this study revealed that
both cell types became brown or dark-brown from day
7 until day 14 of osteoblast differentiation (Figure 4).
When the cells are treated with a silver nitrate solution,
the silver is deposited by replacing the calcium that had
been reduced by the strong light, thereby allowing the
mineralized calcium nodules to be visualized as metallic
silver. After von Kossa staining, osteoblasts can be visua-
lized as brown or black, representing nodules that con-
tain calcium salts. Previous studies have reported that
mesenchymal stem cells differentiated into chondrogenic
and osteogenic cells deposit calcium mineral nodules
revealed by von Kossa staining [36]. The presence of
calcium nodules concomitant with the increase of ALP
activity and the activation of the Opn gene showed that
the respective cells had differentiated into matured
osteoblasts.
In some cases, the cells became light-brown, indicating
they were less developed (Figure 4A). Tsuang et al [11]
used von Kossa staining to quantify the formation of
mineralization nodules in osteoblasts cultures. This is
most notable when comparing semi-differentiated and
fully differentiated osteoblasts. We categorized the semi-
differentiated and fully differentiated osteoblasts based on
the color intensity of the stained nodules. Light-brown
color represented the semi-differentiated cells, while dark-
brown or black indicated fully differentiated cells. Our
observations showed that mononucleated and MC3T3-E1
cells had a slightly higher proportion of semi-differentiated
cells than fully differentiated osteoblasts (Figure 5).
Figure 7 Percentage of cells differentiated into osteoclast. The percentages of differentiated cells were calculated upon 10 days of
osteoclast differentiation.
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activity and the activation of CatK during osteoclast dif-
ferentiation reflected the increased number of fully differ-
entiated osteoclasts. The multinucleated cells, which are
quite large in size, were observed at least after 5 days cul-
turing in osteoclast differentiation media. From the quan-
tification percentage of both differentiated cells, we found
that not all cells were differentiated into osteoblasts and
osteoclasts (Figure 5 and 7). We believe that this could
have resulted from differences in the stemness of the
cells and the heterogeneity of our isolated cells. In the
in vitro system, not all of the heterogeneous cells differ-
entiated when induced with osteoclastic medium [37].
This phenomenon was studied by Stockholm et al [38],
who suggested that the differentiation of heterogeneous
cell populations, especially stem cells, depends on extrin-
sic and intrinsic factors. These extrinsic and intrinsic fac-
tors may lead to changes in the gene expression patterns
among heterogeneous cells.
Conclusion
In conclusion, only mononucleated cells successfully dif-
ferentiated into both osteoblasts and osteoclasts in vitro,
whereas MC3T3-E1 only differentiated into osteoblasts.
The differentiation capacities of these stem and progeni-
tor cells have been determined and characterized, sug-
gesting that the capacity to differentiate into more than
one type of cell is only present in the (mononucleated)
stem cells. Our study involved cells primarily isolated
from peripheral blood. Nonetheless, these distinctions
between the cell types should be emphasized rather
than ignored, as they can be used to test specific
hypotheses in the controversial area of stem cell defini-
tion and distinction.
Methods
Primary Cell Isolation and MC3T3-E1 Cell Line Culture
Peripheral blood mononucleated cells from buffy coats
obtained from healthy 4-to 6-week-old mice were iso-
lated by density centrifugation with Ficoll Paque™ Plus
(G.E Healthcare, UK). Briefly, the buffy coat prepara-
tions were diluted 1:3 with Hanks’ Balanced Salt Solu-
tion (HBSS) (Sigma, USA). Diluted buffy coat was laid
onto 1.5 mL of Ficoll Paque™ Plus and centrifuged at
400 × g for 30 min at room temperature. The buffy coat
was separated into four layers of different densities, con-
sisting of granulocytes and erythrocytes at the bottom,
the polymorphonuclear cells in the Ficoll Paque layer,
mononuclear cells above that, and plasma at the top.
The peripheral blood mononucleated cells were recov-
ered after discarding the plasma, washed twice with
phosphate-buffered saline (PBS) (Sigma, USA), and cul-
tured in selective proliferation media consisting of
a-Minimal Essential Medium (a-MEM) (Invitrogen,
USA) supplemented with 10% (v/v) newborn calf serum
(NBCS) (Invitrogen, USA) and penicillin-streptomycin
solution (with final concentration of 500 unit/mL peni-
cillin G sodium and 500 μg/mL streptomycin sulfate)
(Invitrogen, USA) for 14 d prior to analysis of osteoblast
and osteoclast differentiation. The selective proliferation
media was then supplemented with differentiation fac-
tors, including 50 μg/mL ascorbic acid (Sigma, USA)
and 10 mM b-glycerophosphate (Sigma, USA), to differ-
entiate mononucleated cells into osteoblast cells. For
osteoclast differentiation, 10 ng/mL RANKL (Peprotech,
USA) and 5 ng/mL M-CSF (Peprotech, USA) were
added to the proliferation medium.
Progenitor cells of the MC3T3-E1 subclone C14
(MC3T3-E1/C14) pre-osteoblast cell line (ATCC No:
CRL-2596™) were used in this study. Cells were main-
tained in a-MEM supplemented with 1 mM sodium
pyruvate (Sigma, USA) plus 10% (v/v) fetal bovine
serum (FBS) (Invitrogen, USA). For differentiation
assays, cells were plated at 5 × 10
4cells/mL. As men-
tioned previously, differentiation was induced by the
addition of 50 ng/mL ascorbic acid (Sigma, USA) and
10 mM b-glycerophosphate (Sigma, USA) to standard
growth medium for osteoblasts differentiation. For
osteoclast differentiation, 10 ng/mL RANKL (Peprotech,
USA) and 5 ng/mL M-CSF (Peprotech, USA) were
added to the proliferation medium. The medium was
changed every 3-4 d.
Alkaline Phosphatase (ALP) Assay
The cells were washed with complete growth medium fol-
lowed by PBS. The whole cells were incubated in 0.1 M
NaHCO3-NaCO3 buffer (pH 10), containing 0.1% (v/v)
Triton X-100, 2 mM MgSO4 and 6 mM p-nitrophenol
phosphate (pNPP) for 30 min at 37°C. The reaction was
stopped by adding 1 mL 1.5 M NaOH, and the absorbance
was measured at 405 nm. The ALP activity is represented
as specific activity. The specific activity was determined by
unit activity per total protein content (mg) and protein
content was measured using Bradford method. One unit
of ALP activity represents the hydrolysis of 1 μMp N P P
per minute at 37°C. The ALP specific activity was pre-
sented in percentage value, which was compared to ALP
specific activity in control cells (cells culture in standard
growth medium) that act as basal activity (100%).
Tartrate-Resistant Acid Phosphatase (TRAP) Assay
The cells were washed with PBS and incubated with
50 μL sodium acetate buffer (50 mM, pH 5.5) contain-
ing Triton X-100 (0.1% v/v) at -20°C for 40 min. The
cultures were then centrifuged at 800 × g for 5 min.
The supernatant was transferred to new fresh tubes.
Approximately 500 μL PBS were added to each tube.
TRAP enzyme activity was assayed using p-nitrophenyl
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Page 10 of 12phosphate (pNPP) as substrate in an incubation medium
containing 10 mM pNPP, 0.1 M sodium acetate
(pH 5.8), 0.15 M KCl, 0.1% (v/v) Triton X-100, 10 mM
sodium tartrate, 1 mM ascorbic acid and 0.1 mM FeCl3.
The p-nitrophenol was liberated into p-nitrophenylate
after 1 h of incubation at 37°C, and the reaction was
stopped by adding 500 μLo f0 . 6MN a O H .T h ea b s o r -
bance was immediately taken at 405 nm using a spectro-
photometer. TRAP activity is expressed as hydrolysis of
1 μM pNPP per minute at 37°C. The specific activity
was determined by unit activity per total protein content
(mg) as mentioned earlier. The TRAP specific activity
was presented in percentage value, which was compared
to TRAP specific activity in control cells (cells culture
in standard growth medium) that act as basal activity
(100%).
Molecular Assay by RT-PCR
Total RNA was isolated from both types of cells using
TRI-Reagent (Sigma, USA) according to the manufac-
turer’s instructions. Absorbance at 260 nm and 280 nm
was used to measure the RNA purity; an A260:A280
ratio of 1.8-2.0 was acceptable. Reverse Transcriptase
polymerase chain reaction (RT-PCR) was performed
with AMV reverse transcriptase and Tfl DNA polymer-
ase in the Access RT-PCR System (Promega Corpora-
tion, USA). The primers were designed by using Primer
Premier 5.0 based on the sequences of Gapdh (accession
number: NM 008084), Opn (accession number: X51834)
CatK (accession number NM 007802) and Sca-1 (acces-
sion number: NM 007802) obtained from NCBI. Table 1
shows the specific primer sequences that have been
designed for RT-PCR reaction.
The RT-PCR was carried out in a Mastercyler Gradi-
ent (Eppendorf, Germany). Reverse transcription (RT)
was performed in a program of 45°C for 45 min and
pre-denaturation at 94°C for 2 min. The amplification
program was as follows: 40 cycles of three-step amplifi-
cation (denaturation, 94°C for 30 s; annealing, 62°C
(Gapdh and Opn)o r6 3 ° C( CatK and Sca-1)f o r6 0s ;
and extension, 68°C for 60 s). A final extension step at
68°C for 7 min was then carried out. Detection of the
PCR amplicons was performed by size fractionation by
1% (w/v) agarose gel electrophoresis.
Von Kossa and May Grunwald-Giemsa Staining
Approximately 5 × 10
5 cells/mL were centrifuged at 75 × g
for 5 min. The pellet was smeared onto a glass slide and
left to air-dry for about 1 to 2 h. The cells were then
labeled with von Kossa and May Grunwald-Giemsa stain-
ing for osteoblasts and osteoclasts, respectively.
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For von Kossa staining, the cells were fixed with 10%
(v/v) formalin in PBS for 30 min and washed with
deionized water three times. Then, the cells were stained
with freshly prepared 5% (v/v) silver nitrate solution for
30 min and washed well with deionized water three
times. Next, the cells were developed with fresh 5% (v/v)
sodium carbonate in 25% (v/v) formalin more than 5 min
for mineral and matrix staining. After three washes with
deionized water, the cells were finally fixed with 5% (v/v)
sodium thiosulfate for 2 min to remove un-reacted silver
nitrate. Finally, the cells were washed well with deionized
water three times and air-dried.
May Grunwald-Giemsa staining was carried out with
May-Grunwald’s eosinmethylene blue solution (Merck,
Germany) and Giemsa solution (Sigma, Germany). May
Grunwald-Giemsa staining started with slides immersed
in 100% (v/v) May-Grunwald for 4 min. The slides were
then transferred directly to 4% (v/v) Giemsa for 4 min
and briefly rinsed with distilled water. Excess dye was
wiped and air-dried. The von Kossa- and May-Grunwald
Giemsa-stained areas were viewed by light microscopy.
Approximately 400 cells were counted randomly from
each slide. Each experiment consists of 3 different slides.
Each generated data was based on 3 independent experi-
ments. Statistical analyses were done using paired t-test
using Microsoft Excel 2007 program.
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CatK Forward
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3’
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3’
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5’GTGTTGGTGGTGGGCTAC
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Sca-1; Stem cell antigen-1 as murine hematopoietic stem cell marker.
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